C07D 471/18
Bridged systems
C07D471/18 (Bridged systems) appears on 364 US grants and 485 published applications in this corpus.
Search patents in C07D- Granted patents
- 364
- Published applications
- 485
- Assignees
- 238
- Inventors
- 1,516
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 4 | 0 |
| 1990 | 2 | 0 |
| 1991 | 4 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 5 | 0 |
| 1996 | 4 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 3 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 0 |
| 2002 | 2 | 2 |
| 2003 | 2 | 3 |
| 2004 | 2 | 5 |
| 2005 | 1 | 6 |
| 2006 | 4 | 3 |
| 2007 | 3 | 11 |
| 2008 | 4 | 21 |
| 2009 | 7 | 8 |
| 2010 | 4 | 18 |
| 2011 | 11 | 19 |
| 2012 | 9 | 13 |
| 2013 | 13 | 24 |
| 2014 | 17 | 22 |
| 2015 | 33 | 23 |
| 2016 | 16 | 23 |
| 2017 | 20 | 29 |
| 2018 | 20 | 21 |
| 2019 | 18 | 16 |
| 2020 | 15 | 30 |
| 2021 | 19 | 25 |
| 2022 | 19 | 27 |
| 2023 | 23 | 34 |
| 2024 | 20 | 39 |
| 2025 | 20 | 33 |
| 2026 | 9 | 30 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Indirubin derivatives having heterobicyclic moieties and the use thereof15 Sep 2026US 12,735,404 B2Pelemed Co., Ltd.
- Tetrahydroisoquinoline derivatives for the treatment of red blood disorders and inflammatory diseases28 Jul 2026US 12,692,274 B2Sanofi
- HDAC6 inhibitors and uses thereof16 Jun 2026US 12,655,106 B2Eikonizo Therapeutics, Inc.
- N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as GPR65 modulators for the treatment of cancer9 Jun 2026US 12,649,744 B2Pathios Therapeutics Limited
- Endocyclic pyrimidinone compounds, and preparation methods, compositions and use thereof19 May 2026US 12,630,551 B2Neusco Biotech Limited
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Compounds capable of modulating gpr6524 Sep 2026US 2026/0285863 A1Pathios Therapeutics Limited
- Bridged tricyclic carbamoylpyridone compounds and uses thereof17 Sep 2026US 2026/0272961 A1Gilead Sciences, Inc.
- Kif modulator compounds and methods of use10 Sep 2026US 2026/0265254 A1Iambic Therapeutics, Inc.
- Process for the preparation of (6s,9r)-3-oxo-3,5,6,7,8,9-hexahydro-2h-6,9-epiminocyclohepta[c]pyridazine-10-carboxamide derivatives3 Sep 2026US 2026/0258043 A1Pathios Therapeutics Limited
Most cited
By later US patents
- Oxepane isomers of rapamycin useful as immunosuppressive agents56US 5,221,740 AAmerican Home Products Corporation · 1993
- Substituted 2,3,4,5,7,9,13,13a-octahydropyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazepines and methods for treating viral infections49US 9,216,996 B2Gilead Sciences, Inc. · 2015
- Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities46US 5,373,093 A1994
- Bridged heterocyclic compounds and methods of use40US 8,546,381 B2Medivation Technologies, Inc. · 2013
- Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof35US 5,011,846 AMerrell Dow Pharmaceuticals Inc. · 1991